New Percutaneous Approaches for the Treatment of Heavily Calcified Mitral Valve Stenosis

J Clin Med. 2022 Oct 30;11(21):6444. doi: 10.3390/jcm11216444.

Abstract

Important breakthroughs have considerably improved the outcomes of the percutaneous treatment of valvular heart diseases during the last decades. However, calcium deposition and progressive calcification of the left-sided heart valves present a challenge with prognostic implications that have not been addressed until recently. In the case of native mitral stenosis with no surgical options, a compelling need for tackling heavily calcified valves has led to the development of novel debulking techniques and to the use of aortic balloon-expandable bioprosthesis in the mitral position. In this section of the special issue "Mitral Valve Disease: State of the Art", we will review standard approaches and indications for the treatment of native mitral stenosis; summarize these two innovative solutions and their evidence, describing both procedures in a "step-by-step" fashion; and briefly comment on future directions in this field.

Keywords: lithotripsy; mitral annular calcifications; mitral stenosis; percutaneous mitral commissurotomy; percutaneous valve intervention; transcatheter valves; valvular heart disease.

Publication types

  • Review

Grants and funding

This research received no external funding.